Osteoprotegerin Gene as a Biomarker in the Development of Osteoporosis in Postmenopausal Women
Filip Przerwa, Izabela Uzar, Anna Bogacz, Katarzyna Kotrych, Tadeusz Sulikowski, Marlena Wolek, Adam Kamiński, Paweł Ziętek, Bogusław Czerny · 2023
Read Osteoprotegerin Gene as a Biomarker in the Development of Osteoporosis in Postmenopausal Women by Filip Przerwa, Izabela Uzar, Anna Bogacz, Katarzyna Kotrych, Tadeusz Sulikowski, Marlena Wolek, Adam Kamiński, Paweł Ziętek, Bogusław Czerny (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10740651.txt.
Description
Przerwa and eight co-authors study a bone gene as a marker for osteoporosis after menopause, in work from twenty twenty-three. Osteoporosis thins bone and breaks down its inner structure across the whole skeleton. It arises when bone removal outpaces bone building over many years.
After menopause, estrogen falls sharply. Estrogen normally restrains bone removal, so its loss speeds thinning. Osteoprotegerin is a protein that blocks the cells that remove bone. Variation in its gene may mark women at higher risk of rapid loss. A genetic marker could flag who needs early bone density checks and preventive treatment.
Catalog record
| CREATOR | Filip Przerwa, Izabela Uzar, Anna Bogacz, Katarzyna Kotrych, Tadeusz Sulikowski, Marlena Wolek, Adam Kamiński, Paweł Ziętek, Bogusław Czerny |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |